Author: BusinessWire

Webcasts scheduled for February 26, March 9 and March 15
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metaboli…

Webcasts scheduled for February 26, March 9 and March 15
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metaboli…

DUBLIN–(BUSINESS WIRE)–The “Global Anterior uveitis treatment Market 2020-2026” report has been added to ResearchAndMarkets.com’s offering.

The global anterior uveitis treatment market is projected to witness considerable growth during the forecast …

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, to…

―New State-of-the-Art Facilities Will Triple the Company’s Space and Greatly Increase Its Manufacturing Capacity for APIs for Clinical Trial Materials and Ultimately Commercial Production―
EUGENE, Ore.–(BUSINESS WIRE)–#cascadechemistry–Cascade Chem…

LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its fi…

—Leading Developer and Manufacturer of APIs Acquires an Established Custom Research and Manufacturing Services Provider Focused on Pharmaceutical Key Starting Materials and Advanced Drug Intermediates—
PETAH TIKVAH, Israel–(BUSINESS WIRE)–#pharmaceu…

Most used oncology pathway technology solution enables evidence-based decisions and accelerates prior authorization, resulting in smarter, quicker patient treatment
IRVING, TEXAS–(BUSINESS WIRE)–#ehr–OntadaTM, McKesson’s oncology technology and ins…

Former CEO, David Nixon, Transitions to Executive Chairman Role
ST. PETERSBURG, Fla.–(BUSINESS WIRE)–InformedDNA®, the nation’s leading genetics services organization, today announced that Dan Lieber has joined the company as chief executive officer…